Pharmaceutical Chemistry Journal is a pivotal publication in the field of pharmaceutical sciences, renowned for its in-depth articles and research findings. Published by Springer in the United States, this journal provides a crucial platform for researchers, students, and professionals dedicated to advancing drug discovery and pharmacology. With an ISSN of 0091-150X and an E-ISSN of 1573-9031, this journal has consistently aimed to promote scholarly communication and innovation within its scope since its inception in 1967. Despite its current Category Quartiles ranking of Q4 in both Drug Discovery and Pharmacology, the journal remains a valuable resource for disseminating new ideas and findings that contribute to the scientific community. Researchers benefit from the journal's commitment to high-quality peer-reviewed content, even in an environment where open access options are currently not available. As the field evolves, the Pharmaceutical Chemistry Journal continues to play an important role in shaping future advancements in drug development and safety.

Advances in Pharmacological and Pharmaceutical Sciences is a premier open-access journal published by Hindawi Ltd. based in the United Kingdom. Established in 2020, the journal swiftly garnered attention for its commitment to disseminating high-quality research in the realms of pharmacology, toxicology, and pharmaceutical sciences. It holds a commendable impact with notable quartile rankings, including Q2 in both Organic Chemistry and Pharmacology, indicating its importance within these disciplines. By embracing an open-access model, the journal ensures that research findings are widely available, promoting increased visibility and collaboration among researchers, professionals, and students globally. With an ongoing convergence of insights projected through 2024, Advances in Pharmacological and Pharmaceutical Sciences aims to address critical issues and advancements in drug development and therapeutic practices, making it an invaluable resource for those at the forefront of scientific inquiry in pharmacology and related fields.

The Chinese Journal of Natural Medicines, published by the esteemed CHINESE JOURNAL NATURAL MEDICINES, plays a pivotal role in the exploration and advancement of complementary and alternative medicine. With an ISSN of 2095-6975 and an E-ISSN of 1875-5364, this journal is recognized for its commitment to high-quality research and innovative findings in the realms of drug discovery and miscellaneous medical fields. Operating from China, it has earned a prestigious reputation in the academic community, achieving Q1 status in Complementary and Alternative Medicine and Q2 rankings in both Drug Discovery and Miscellaneous Medicine as of 2023, solidifying its influence within the scientific discourse. Researchers and professionals will find valuable insights here as the journal explores the intersection of traditional natural medicines with modern pharmacological science, making it an essential resource for anyone dedicated to the field. With a convergence period from 2004 to 2024, the journal continues to champion open dialogue and disseminate significant findings critical for the development of effective natural therapies.

PHARMACEUTICAL BIOLOGY, published by Taylor & Francis Ltd, is a prominent open-access journal that has been a cornerstone of research in the life sciences since its convergence in 1961. With a strong focus on Complementary and Alternative Medicine, Pharmaceutical Science, and Drug Discovery, this journal is dedicated to disseminating groundbreaking research that intersects pharmaceuticals and biology. Acknowledged for its rigorous peer-review process, it holds a prestigious Q1 ranking in Pharmaceutical Science and exemplifies the commitment to quality and impact in the field, boasting an impressive Scopus rank of #14/105 in the complementary and alternative medicine category. Researchers keen on advancing their knowledge in these fields will find PHARMACEUTICAL BIOLOGY an invaluable resource, offering accessibility since its shift to open access in 2017. This journal presents a platform for innovative studies that contribute to the evolving understanding of pharmaceutical applications and biological interactions, serving as an essential hub for researchers, professionals, and students alike.

Boletin Latinoamericano y del Caribe de Plantas Medicinales y Aromaticas, published by MS-EDITIONS, serves as a vital platform for the dissemination of research and insights related to medicinal and aromatic plants in Latin America and the Caribbean. With its ISSN 0717-7917, this journal operates within multiple scientific categories, achieving notable rankings, including Q3 in Complementary and Alternative Medicine and Q4 in Drug Discovery, Pharmacology, and Plant Science for 2023. The journal is committed to providing a space for high-quality research that supports the exploration of traditional and innovative uses of plant resources in health and wellness. Researchers, professionals, and students are encouraged to contribute their findings from 2008 through 2024, fostering a rich collaborative environment that advances knowledge in this essential field. Though not officially listed as open access, Boletin Latinoamericano y del Caribe de Plantas Medicinales y Aromaticas remains a critical resource for those invested in the science of plant-based therapies and their implications in modern medicine.

JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH is a prestigious publication in the field of natural products, focusing on valuable research spanning analytical chemistry, pharmacology, and complementary medicine. Published by Taylor & Francis Ltd in the United Kingdom, this journal has established itself as a key resource for academics and professionals seeking to explore advancements in drug discovery and organic chemistry. With a converged publication timeline from 1998 to 2024, the journal boasts several commendable category quartiles as of 2023, reflecting its robust standing in the research community: Q2 in Complementary and Alternative Medicine, Q3 in multiple domains including Analytical Chemistry and Organic Chemistry, and Q4 in Molecular Medicine. Although it currently does not offer open access, the journal remains a valuable compendium for empirical research and innovative studies in areas such as pharmacology and medicinal chemistry. Researchers, professionals, and students alike will find the JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH to be an essential platform for sharing groundbreaking findings and fostering collaborations that lead to significant advancements in science and health.

PHYTOMEDICINE is a premier journal published by Elsevier GmbH, based in Germany, that serves as a central hub for the dissemination of innovative research in the fields of Complementary and Alternative Medicine, Drug Discovery, Molecular Medicine, Pharmaceutical Science, and Pharmacology. Established in 1994, this multidisciplinary journal has rapidly ascended to a Q1 ranking across these categories in 2023, highlighting its significance and impact within the scientific community. With its current Scopus rankings placing it in the top tiers—such as #3 in Complementary and Alternative Medicine and #17 in Pharmaceutical Science—PHYTOMEDICINE is recognized for its commitment to publishing high-quality, peer-reviewed articles that advance our understanding of phytotherapeutics and their applications. Researchers and professionals in the field benefit from its rigorous standards and comprehensive coverage, while students gain access to essential findings that shape contemporary practices in medicine and pharmacology. Its continued focus on critical advancements ensures that PHYTOMEDICINE remains a vital resource for anyone involved in the exploration of medicinal plants and their potential health benefits.

PLANTA MEDICA is a premier journal dedicated to advancing the field of medicinal plant research, published by Georg Thieme Verlag KG in Germany. With an ISSN of 0032-0943 and an E-ISSN of 1439-0221, this journal has been a cornerstone of scholarly communication since its inception in 1961. Recognized for its rigorous peer-review process, PLANTA MEDICA holds a notable reputation in the academic landscape, featuring a 2023 Q2 ranking in categories such as Analytical Chemistry and Pharmaceutical Science, along with respectable Q3 rankings in Drug Discovery and Molecular Medicine. The journal focuses on the synthesis, pharmacological, and biochemical assessment of phytochemicals, making it an essential resource for researchers, professionals, and students alike who are engaged in the exploration of complementary and alternative medicine. Although it does not offer open access options, its content is instrumental in identifying new therapeutic agents derived from plants, thereby underscoring its importance in drug discovery and holistic health research.

JOURNAL OF NATURAL PRODUCTS, published by the American Chemical Society, is a premier academic journal that focuses on the study and application of natural products in various scientific domains. With an esteemed ISSN of 0163-3864 and an E-ISSN of 1520-6025, this journal caters to a wide range of fields, including Analytical Chemistry, Complementary and Alternative Medicine, Drug Discovery, Molecular Medicine, Organic Chemistry, Pharmaceutical Science, and Pharmacology. The journal consistently ranks in the Q1 and Q2 quartiles across these categories, reflecting its significant contribution and rigorous standards in the scientific community. Notably, its Scopus rankings highlight its influence, with notable percentiles across various fields, including a 93rd percentile in Complementary and Alternative Medicine. The JOURNAL OF NATURAL PRODUCTS aims to advance knowledge in the field by publishing groundbreaking research articles, reviews, and critical insights, making it an essential resource for researchers, professionals, and students dedicated to exploring the vast potential of natural substances. This journal addresses complex challenges and fosters innovative developments, further establishing its place as a cornerstone in natural products research. Access to published articles may vary, underscoring the need for individuals in this field to stay connected with the latest advances through the journal's offerings.

NATURAL PRODUCT RESEARCH is a distinguished journal published by Taylor & Francis Ltd, dedicated to advancing the field of natural product science through the dissemination of high-quality research. Established in 2003, this journal serves as a pivotal platform for scholars in Analytical Chemistry, Biochemistry, Organic Chemistry, and Plant Science, boasting an impressive categorization including Q2 in Plant Science and Q3 in the other disciplines for 2023. With a current Scopus ranking that highlights its significance within various scientific communities, NATURAL PRODUCT RESEARCH reflects the complexities and innovations associated with natural compounds and their applications. Researchers, professionals, and students will find valuable insights and breakthroughs that contribute to the understanding of bioactive compounds and their roles in health and environmental sustainability. Access options are available, ensuring that the latest findings are accessible to a global audience. As this journal continues to publish until 2024, it remains an essential resource for those at the forefront of natural product research.